AAAAAA
Results: 26-50/51
Authors:
KIVISTO KT
KROEMER HK
Citation: Kt. Kivisto et Hk. Kroemer, USE OF PROBE DRUGS AS PREDICTORS OF DRUG-METABOLISM IN HUMANS, Journal of clinical pharmacology, 37(1), 1997, pp. 40-48
Authors:
MURDTER TE
SPERKER B
FRIEDEL G
LINDER A
KIVISTO KT
MCCLELLAN M
FRITZ P
BOSSLET K
KROEMER HK
Citation: Te. Murdter et al., BIOACTIVATION OF A GLUCURONYL-SPACER-DOXORUBICIN PRODRUG BY BETA-GLUCURONIDASE - A STUDY USING THE HUMAN LUNG PERFUSION MODEL, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 455-455
Authors:
NEUVONEN PJ
KANTOLA T
KIVISTO KT
Citation: Pj. Neuvonen et al., EFFECT OF ITRACONAZOLE ON SERUM CONCENTRATIONS OF SIMVASTATIN AND PRAVASTATIN, Atherosclerosis, 134(1-2), 1997, pp. 131-131
Authors:
VILLIKKA K
KIVISTO KT
LUURILA H
NEUVONEN PJ
Citation: K. Villikka et al., RIFAMPIN REDUCES PLASMA-CONCENTRATIONS AND EFFECTS OF ZOLPIDEM, Clinical pharmacology and therapeutics, 62(6), 1997, pp. 629-634
Authors:
KIVISTO KT
LAMBERG TS
KANTOLA T
NEUVONEN PJ
Citation: Kt. Kivisto et al., PLASMA BUSPIRONE CONCENTRATIONS ARE GREATLY INCREASED BY ERYTHROMYCINAND ITRACONAZOLE, Clinical pharmacology and therapeutics, 62(3), 1997, pp. 348-354
Authors:
VILLIKKA K
KIVISTO KT
BACKMAN JT
OLKKOLA KT
NEUVONEN PJ
Citation: K. Villikka et al., TRIAZOLAM IS INEFFECTIVE IN PATIENTS TAKING RIFAMPIN, Clinical pharmacology and therapeutics, 61(1), 1997, pp. 8-14
Authors:
MURDTER TE
SPERKER B
KIVISTO KT
MCCLELLAN M
FRITZ P
FRIEDEL G
LINDER A
BOSSLET K
TOOMES H
DIERKESMANN R
KROEMER HK
Citation: Te. Murdter et al., ENHANCED UPTAKE OF DOXORUBICIN INTO BRONCHIAL-CARCINOMA - BETA-GLUCURONIDASE MEDIATES RELEASE OF DOXORUBICIN FROM A GLUCURONIDE PRODRUG (HMR-1826) AT THE TUMOR SITE, Cancer research, 57(12), 1997, pp. 2440-2445
Authors:
LAINE K
KIVISTO KT
PELTTARI S
NEUVONEN PJ
Citation: K. Laine et al., THE EFFECT OF ACTIVATED-CHARCOAL ON THE ABSORPTION OF FLUOXETINE, WITH SPECIAL REFERENCE TO DELAYED CHARCOAL ADMINISTRATION, Pharmacology & toxicology, 79(5), 1996, pp. 270-273
Authors:
KIVISTO KT
BOOKJANS G
FROMM MF
GRIESE EU
MUNZEL P
KROEMER HK
Citation: Kt. Kivisto et al., EXPRESSION OF CYP3A4, CYP3A5 AND CYP3A7 IN HUMAN DUODENAL TISSUE, British journal of clinical pharmacology, 42(3), 1996, pp. 387-389
Authors:
LINDER A
FRIEDEL G
FRITZ P
KIVISTO KT
MCCLELLAN M
TOOMES H
Citation: A. Linder et al., THE EX-VIVO ISOLATED, PERFUSED HUMAN LUNG MODEL - DESCRIPTION AND POTENTIAL APPLICATIONS, The thoracic and cardiovascular surgeon, 44(3), 1996, pp. 140-146
Authors:
KIVISTO KT
GRIESE EU
FRITZ P
LINDER A
HAKKOLA J
RAUNIO H
BEAUNE P
KROEMER HK
Citation: Kt. Kivisto et al., EXPRESSION OF CYTOCHROME-P-450 3A ENZYMES IN HUMAN LUNG - A COMBINED RT-PCR AND IMMUNOHISTOCHEMICAL ANALYSIS OF NORMAL TISSUE AND LUNG-TUMORS, Naunyn-Schmiedeberg's archives of pharmacology, 353(2), 1996, pp. 207-212
Authors:
LEHTO P
LAINE K
KIVISTO KT
NEUVONEN PJ
Citation: P. Lehto et al., THE EFFECT OF PH ON THE IN-VITRO DISSOLUTION OF 3 2ND-GENERATION SULFONYLUREA PREPARATIONS - MECHANISM OF ANTACID-SULFONYLUREA INTERACTION, Journal of Pharmacy and Pharmacology, 48(9), 1996, pp. 899-901
Authors:
KIVISTO KT
FRITZ P
LINDER A
FRIEDEL G
BEAUNE P
KROEMER HK
Citation: Kt. Kivisto et al., IMMUNOHISTOCHEMICAL LOCALIZATION OF CYTOCHROME-P450 3A IN HUMAN PULMONARY CARCINOMAS AND NORMAL BRONCHIAL TISSUE, HISTOCHEM C, 103(1), 1995, pp. 25-29
Authors:
KIVISTO KT
LINDER A
FRIEDEL G
BEAUNE P
BELLOC C
KROEMER HK
FRITZ P
Citation: Kt. Kivisto et al., IMMUNOHISTOCHEMICAL LOCALIZATION OF CYTOCHROME-P450 2E1 IN HUMAN PULMONARY-CARCINOMA AND NORMAL BRONCHIAL TISSUE, Virchows Archiv, 426(3), 1995, pp. 243-247
Authors:
KIVISTO KT
KROEMER HK
EICHELBAUM M
Citation: Kt. Kivisto et al., THE ROLE OF HUMAN CYTOCHROME-P450 ENZYMES IN THE METABOLISM OF ANTICANCER AGENTS - IMPLICATIONS FOR DRUG-INTERACTIONS, British journal of clinical pharmacology, 40(6), 1995, pp. 523-530
Authors:
LEHTO P
KIVISTO KT
Citation: P. Lehto et Kt. Kivisto, EFFECTS OF MILK AND FOOD ON THE ABSORPTION OF ENOXACIN, British journal of clinical pharmacology, 39(2), 1995, pp. 194-196
Authors:
LAINE K
KIVISTO KT
NEUVONEN PJ
Citation: K. Laine et al., THE EFFECT OF ACTIVATED-CHARCOAL ON THE ABSORPTION AND ELIMINATION OFASTEMIZOLE, Human & experimental toxicology, 13(7), 1994, pp. 502-505
Authors:
ROIVAS L
KIVISTO KT
NEUVONEN PJ
Citation: L. Roivas et al., DESORPTION OF FUROSEMIDE FROM CHARCOAL IN-VITRO AND IN MAN, International journal of clinical pharmacology and therapeutics, 32(7), 1994, pp. 365-369
Authors:
NEUVONEN PJ
KIVISTO KT
Citation: Pj. Neuvonen et Kt. Kivisto, ENHANCEMENT OF DRUG ABSORPTION BY ANTACIDS - AN UNRECOGNIZED DRUG-INTERACTION, Clinical pharmacokinetics, 27(2), 1994, pp. 120-128
Authors:
KIVISTO KT
NEUVONEN PJ
KLOTZ U
Citation: Kt. Kivisto et al., INHIBITION OF TERFENADINE METABOLISM - PHARMACOKINETIC AND PHARMACODYNAMIC CONSEQUENCES, Clinical pharmacokinetics, 27(1), 1994, pp. 1-5
Authors:
LEHTO P
KIVISTO KT
NEUVONEN PJ
Citation: P. Lehto et al., THE EFFECT OF FERROUS SULFATE ON THE ABSORPTION OF NORFLOXACIN, CIPROFLOXACIN AND OFLOXACIN, British journal of clinical pharmacology, 37(1), 1994, pp. 82-85
Authors:
LEHTO P
KIVISTO KT
Citation: P. Lehto et Kt. Kivisto, EFFECT OF SUCRALFATE ON ABSORPTION OF NORFLOXACIN AND OFLOXACIN, Antimicrobial agents and chemotherapy, 38(2), 1994, pp. 248-251
Authors:
KIVISTO KT
KALLIO A
NEUVONEN PJ
Citation: Kt. Kivisto et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF TRANSDERMAL DEXMEDETOMIDINE, European Journal of Clinical Pharmacology, 46(4), 1994, pp. 345-349
Authors:
LEHTO P
KIVISTO KT
Citation: P. Lehto et Kt. Kivisto, DIFFERENT EFFECTS OF PRODUCTS CONTAINING METAL-IONS ON THE ABSORPTIONOF LOMEFLOXACIN, Clinical pharmacology and therapeutics, 56(5), 1994, pp. 477-482
Authors:
KIVISTO KT
NEUVONEN PJ
Citation: Kt. Kivisto et Pj. Neuvonen, ACTIVATED-CHARCOAL FOR CHLOROQUINE POISONING, BMJ. British medical journal, 307(6911), 1993, pp. 1068-1068